
Shares of MLNM are up almost 50% in pre-market trading following the overnight announcement of a buyout offer from Takeda Pharma.
Takeda's cash offer is worth $25 per share, more than a 50 percent premium over Millennium's Wednesday closing share price of $16.35.
Thursday, April 10, 2008
MLNM Skyrockets On Buyout Offer.........
at
5:48 AM
Labels: biotech, biotech stocks